XPeng Inc/ US98422D1054 /
10/05/2024 21:59:57 | Var. -0.43 | Volume | Denaro- | Lettera- | Capitalizzazione di mercato | Dividend Y. | Rapporto P/E |
---|---|---|---|---|---|---|---|
7.73USD | -5.27% | 405,136 Fatturato: 3.15 mill. |
-Quantità in denaro: - | -Quantità in lettera: - | 5.51 bill.USD | - | - |
GlobeNewswire
14:50
Atossa Therapeutics Announces First Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire
14:50
Outlook Therapeutics® Announces UK Submission of Marketing Authorization Application (MAA) for ONS-5...
GlobeNewswire
14:48
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Squarespace, I...
GlobeNewswire
14:36
DEADLINE TOMORROW: Berger Montague Advises Innoviz Technologies Ltd. (NASDAQ: INVZ) Investors to Inq...
GlobeNewswire
14:35
DeFi Technologies Inc. Featured in Syndicated Broadcast Covering Subsidiary’s AUM of C$748M, a 47.2%...
GlobeNewswire
14:33
Stanley Martin Holdings Acquires Prestige Corporate Development and Prestige Site Works
GlobeNewswire
14:30
Backblaze to Present at the 19th Annual Needham Technology, Media, & Consumer Conference
GlobeNewswire
14:30
Madison Realty Capital and Unity Capital Originate $100 Million Construction Loan for Mixed-Use Mult...
GlobeNewswire
14:30
Checkpoint Therapeutics to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Confere...
GlobeNewswire
14:30
Bitdeer Reports Unaudited Financial Results for the First Quarter of 2024 and Operational Update